XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.2
Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2025
Summary of Significant Accounting Policies [Abstract]  
Schedule of Derivative Liability Measured at Fair Value The table below reflects the activity of derivative liability measured at fair value for the six months ended June 30, 2025:
   Significant Unobservable Inputs
(Level 3)		 
Balance of derivative liability as of January 1, 2025  $127,545 
Initial fair value of derivative liability attributable to Second Warrant (as hereinafter defined) issuance with June 2024 fund raise (see Note 6)   621,353 
Gain from change in the fair value of derivative liability   (446,816)
Reclassification of additional paid-in capital upon conversion   (176,529)
Balance of derivative liability as of June 30, 2025  $125,553 
Schedule of Cash Balances by Geographic Area

At June 30, 2025 and December 31, 2024, the Company’s cash balances by geographic area were as follows:

 

Country:  June 30,
2025		   December 31,
2024		 
United States  $199,227    98.9%  $2,844,522    99.6%
China   2,305    1.1%   11,787    0.4%
Total cash  $201,532    100.0%  $2,856,309    100.0%
Schedule of Securities that were Excluded from the Diluted Per Share

The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive:

 

   Three Months Ended
June 30,		   Six Months Ended
June 30,		 
   2025   2024   2025   2024 
Options to purchase common stock   44,501    47,420    44,501    47,420 
Warrants to purchase common stock   95,746    189,274    95,746    189,274 
Series A convertible preferred stock (*)   
-
    60,000    
-
    60,000 
Series B convertible preferred stock (**)   
-
    194,004    
-
    194,004 
Series C convertible preferred stock (***)   1,452,282    
-
    1,452,282    
-
 
Series D convertible preferred stock (****)   2,074,689    
-
    2,074,689    
-
 
Convertible notes and related accrued interest (*****)   2,436,375    252,889    2,638,734    343,022 
Potentially dilutive securities   6,103,593    743,587    6,305,952    833,720 

 

(*)Assumed the Series A convertible preferred stock (“Series A Preferred Stock”) was converted into shares of common stock of the Company at a conversion price of $150.00 per share.

 

(**)Assumed the Series B convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $56.70 per share.

 

(***)Assumed the Series C convertible preferred stock (“Series C Preferred Stock”) was converted into shares of common stock of the Company at a conversion price of $2.41 per share.

 

(****)Assumed the Series D convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $2.41 per share.

 

(*****)Assumed the convertible notes were converted into shares of common stock of the Company at a conversion price of $1.00 per share for the three and six months ended June 30, 2025. Assumed the convertible notes were converted into shares of common stock of the Company at a conversion price of $67.50 and $22.50 and $15.00 and $11.25 per share for the three and six months ended June 30, 2024.